These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35716840)

  • 1. Response to "Letter to the editor of radiotherapy and oncology regarding of the article "Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer" by Lalonde et al.".
    Lalonde R; Abdelhakiem M; Keller A; Huq MS
    Radiother Oncol; 2022 Dec; 177():242. PubMed ID: 35716840
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor of radiotherapy and oncology regarding of the article "Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer" by Lalonde et al.
    Yang K; Sun C; Yin R
    Radiother Oncol; 2022 Dec; 177():240-241. PubMed ID: 35716839
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer.
    Lalonde R; Abdelhakiem M; Keller A; Huq MS
    Radiother Oncol; 2022 Apr; 169():90-95. PubMed ID: 35202740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.
    Wink KCJ; van Baardwijk A; Troost EGC; De Ruysscher D
    Cancer Treat Rev; 2017 May; 56():8-15. PubMed ID: 28437679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal recurrences after stereotactic body radiotherapy for early stage non-small-cell lung cancer.
    Tibdewal A; Pathak RS; Agarwal JP; Hoskote SS; Mummudi N; Iyer V; Nair AG
    Curr Probl Cancer; 2021 Apr; 45(2):100653. PubMed ID: 32988628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer.
    Kilburn JM; Lester SC; Lucas JT; Soike MH; Blackstock AW; Kearns WT; Hinson WH; Miller AA; Petty WJ; Munley MT; Urbanic JJ
    J Thorac Oncol; 2014 Apr; 9(4):572-6. PubMed ID: 24736084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study of Patients With Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy Using CyberKnife and Linear Accelerator-Based Volumetric Modulated Arc Therapy.
    Deshpande SR; Grubb WR; Kharouta M; Zhang Y; Zheng Y; Podder TK; Towe C; Young B; Machtay M; Biswas T
    Pract Radiat Oncol; 2022; 12(3):200-209. PubMed ID: 35177369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT.
    Kennedy WR; Gabani P; Nikitas J; Robinson CG; Bradley JD; Roach MC
    Radiother Oncol; 2020 Jan; 142():230-235. PubMed ID: 31481272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
    von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
    Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of stereotactic radiotherapy for lung lesions and conventional radiotherapy for nodal areas in primary lung malignancies.
    Kim YJ; Kim SS; Song SY; Choi EK
    Radiat Oncol; 2018 Jul; 13(1):127. PubMed ID: 29996863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer.
    Wink KCJ; Löck S; Rossi M; van Baardwijk A; Belderbos J; de Ruysscher D; Troost EGC
    Radiother Oncol; 2019 Feb; 131():120-126. PubMed ID: 30773178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.
    Sittenfeld SMC; Juloori A; Reddy CA; Stephans KL; Videtic GMM
    Clin Lung Cancer; 2021 May; 22(3):e360-e365. PubMed ID: 32624412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group.
    Giuliani ME; Hope A; Mangona V; Guckenberger M; Mantel F; Peulen H; Sonke JJ; Belderbos J; Werner-Wasik M; Ye H; Grills IS
    Clin Lung Cancer; 2017 Mar; 18(2):162-168. PubMed ID: 27876604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
    Samper Ots PM; Vallejo Ocaña C; Martin Martin M; Celada Álvarez FJ; Farga Albiol D; Almendros Blanco P; Hernandez Machancoses A; Rico Oses M; Flamarique Andueza S; Romero Ruperto F; Maria Bueno C; Amaya Escobar E; Guerrero Gómez LL; Couñago F; Del Pino Alcántara M; Ruiz Villar MJ; Monroy Antón JL; Saez Bueno P; Luna Tirado J; Del Mar Puertas M; Bobo A; Diaz de Cerio Martínez I; Gascon Costoso N; Ferrer Albiach C
    Clin Transl Oncol; 2022 Feb; 24(2):342-349. PubMed ID: 34487307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer.
    Kharod SM; Nichols RC; Henderson RH; Morris CG; Pham DC; Seeram VK; Jones LM; Antonio-Miranda M; Huh S; Li Z; Hoppe BS
    Acta Oncol; 2020 Oct; 59(10):1164-1170. PubMed ID: 32394776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Local Recurrence on Cause-Specific Death After Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Dynamic Prediction Using Landmark Model.
    Ueki K; Matsuo Y; Takeda A; Morita S; Taguri M; Kishi N; Hanazawa H; Tsurugai Y; Mizowaki T
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1135-1143. PubMed ID: 34838867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
    Zhang X; Liu H; Balter P; Allen PK; Komaki R; Pan T; Chuang HH; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1558-65. PubMed ID: 22572078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy for central lung tumors, yes we can!
    Korzets Ceder Y; Fenig E; Popvtzer A; Peled N; Kramer MR; Saute M; Bragilovsky D; Schochat T; Allen AM
    Radiat Oncol; 2018 Apr; 13(1):77. PubMed ID: 29695273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis.
    Wen SW; Han L; Lv HL; Xu YZ; Li ZH; Wang MB; Zhu YG; Su P; Tian ZQ; Zhang YF
    J Invest Surg; 2019 Jan; 32(1):27-34. PubMed ID: 28985095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.